The development of technology of Fludeoxyglucose (18F) for injection, laboratory analysis methods
Journal Title: Фармацевтичний журнал - Year 2017, Vol 1, Issue 1
Abstract
18F-Fluorodeoxyglucose has optimal characteristics for use in nuclear medicine and is a priority among radiopharmaceuticals for the diagnosis of cancer by positron emission tomography (PET). 18F-Fluorodeoxyglucose has the longest half-life with the lowest energy of radiation, it allows to obtain PET images of high contrast at low dose loading on the patient. Low energy positron radiation provides high spatial resolution of PET images. However, the half-life of 18F-Fluorodeoxyglucose is large enough to allow the transportation of radiopharmaceuticals from the centralized production site to diagnostic centers with PET scanners (the so-called PET satellite concept), and to extend the time limits of PET research and synthesis of radiopharmaceuticals [1]. The study is the development of technology and quality control methods to ensure quality at all stages of the production of radiopharmaceuticals 18F-Fluorodeoxyglucose, injection. There was justified 18F-Fluorodeoxyglucose production technology and quality control at all stages of production, based on complex research in the department producing radiopharmaceuticals Ukrainian Center of radiosurgery consisting Clinical Hospital «Feofaniya». Object of study – 18F-Fluorodeoxyglucose, injection, injection is used in nuclear medicine for PET diagnosis of cancer. We used the biopharmaceutical and pharmaceutical methods. For the first time based pharmaceutical research was the rational technology of diagnostic radiopharmaceuticals 18F-Fluorodeoxyglucose, injection for use in PET diagnosis of cancer patients. Methods of controlling drug 18F-Fluorodeoxyglucose, injection according monographs of the State Pharmacopoeia of Ukraine. On the basis of the analysis developed by established methods of control performance specifications and shelf life of radiopharmaceuticals 18F-Fluorodeoxyglucose, injection.
Authors and Affiliations
V. V. Kachaniuk, S. Y. Sarychev
Keywords
Related Articles
- EP ID EP554018
- DOI 10.32352/0367-3057.1.17.07
- Views 67
- Downloads 0
Development of modern antimicrobial foam cleaning product technology
Baby's skin is more sensitive and dry, prone to atopy and needs special care, particularly attention should be paid to foam cleaning tools (shampoos, soaps, gels, etc.). Developing mild foam cleaning product for children...
Scientific and methodological approaches to the assessment of intellectual potential of domestic pharmaceutical companies
Currently, the state and effectiveness of intellectual resources management system define competitiveness, strategic position and prospects of the development of modern pharmaceutical companies. The aim is to study scie...
Researches of the assortment of drugs for the treatment of diabetes II type оn the pharmaceutical market of Ukraine
Type II diabetes is a global pandemic, as evidenced by data from a study by the International Diabetes Federation. The disease is a chronic, progressive process with a special metabolic condition that is characterized by...
Research of the rheological parameters of the combine compounding ointment with hydrocortisone butyrate
Though the range of the industrial semi-solid preparations are quite wide, just compounding ointments allow to combine differences in pharmacological activity of the components in one preparation which provides versatile...
Determination of caffeine with the use of effects of the luminescence Tb (III) ion quenching
Caffeine is a part of many drugs and is widely used in therapeutic practice; therefore, there is the need for careful control of its dosage. For determination of caffeine used spectrophotometric methods, which are not se...